FDA.reportPublic FDA data

IFOSFAMIDE

Substance profile for UNII UM20QQM95Y, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for IFOSFAMIDE
Structure render from PubChem CID 3690

Substance Identity#

UNII
UM20QQM95Y
Preferred term
IFOSFAMIDE
Registry number
3778-73-2
EC number
223-237-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C7H15Cl2N2O2P
Chemical structure for IFOSFAMIDE
Structure render from PubChem CID 3690

Chemical And Database Identifiers#

InChIKey
HOMGKSMUEGBAAB-UHFFFAOYSA-N
SMILES
ClCCNP1(=O)OCCCN1CCCl
RxCUI
5657
PubChem
3690
NCIt
C564
INN ID
2865

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound3690pubchem.ncbi.nlm.nih.gov/compound/3690
PubChem InChIKey SearchHOMGKSMUEGBAAB-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=HOMGKSMUEGBAAB-UHFFFAOYSA-N
RxNorm5657mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=5657
NCI ThesaurusC564ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C564
FDA Substance Registration SystemUM20QQM95Yprecision.fda.gov/uniisearch/srs/unii/UM20QQM95Y
European Community number223-237-3commonchemistry.cas.org/results?q=223-237-3

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTIFEX (IFOSFAMIDE) INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]7
ACTIVE MOIETYIFEX (IFOSFAMIDE) INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]7
ACTIVE INGREDIENTIFOSFAMIDE INJECTION [TEVA PARENTERAL MEDICINES, INC.]7
ACTIVE MOIETYIFOSFAMIDE INJECTION [TEVA PARENTERAL MEDICINES, INC.]7
ACTIVE MOIETYIFOSFAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]5
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, POWDER, FOR SOLUTION [BAXTER HEALTHCARE CORPORATION]5
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]2
ACTIVE MOIETYIFOSFAMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]2
ACTIVE MOIETYIFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]1
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC]1
ACTIVE MOIETYIFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]1
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]1
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYIFOSFAMIDE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC ]1
ACTIVE MOIETYIFOSFAMIDE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]1
ACTIVE INGREDIENTIFOSFAMIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1
ACTIVE MOIETYIFOSFAMIDE INJECTION, SOLUTION [PFIZER LABORATORIES DIV PFIZER INC.]1